Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Cayman Chemical Company, Inc., Ann Arbor, Michigan, USA.
Antioxid Redox Signal. 2021 Nov 1;35(13):1093-1115. doi: 10.1089/ars.2021.0018. Epub 2021 Jul 13.
Protein disulfide isomerase (PDI) and endoplasmic reticulum oxidoreductase 1 (ERO1) are crucial for oxidative protein folding in the endoplasmic reticulum (ER). These enzymes are frequently overexpressed and secreted, and they contribute to the pathology of neurodegenerative, cardiovascular, and metabolic diseases. Tissue-specific knockout mouse models and pharmacologic inhibitors have been developed to advance our understanding of the cell-specific functions of PDI and ERO1. In addition to their roles in protecting cells from the unfolded protein response and oxidative stress, recent studies have revealed that PDI and ERO1 also function outside of the cells. Despite the well-known contributions of PDI and ERO1 to specific disease pathology, the detailed molecular and cellular mechanisms underlying these activities remain to be elucidated. Further, although PDI and ERO1 inhibitors have been identified, the results from previous studies require careful evaluation, as many of these agents are not selective and may have significant cytotoxicity. The functions of PDI and ERO1 in the ER have been extensively studied. Additional studies will be required to define their functions outside the ER.
蛋白质二硫键异构酶(PDI)和内质网氧化还原酶 1(ERO1)对于内质网(ER)中氧化蛋白折叠至关重要。这些酶经常过表达和分泌,并有助于神经退行性、心血管和代谢疾病的发病机制。已经开发了组织特异性敲除小鼠模型和药理学抑制剂,以加深我们对 PDI 和 ERO1 的细胞特异性功能的理解。除了在保护细胞免受未折叠蛋白反应和氧化应激方面的作用外,最近的研究还揭示了 PDI 和 ERO1 也在细胞外发挥作用。尽管 PDI 和 ERO1 对特定疾病发病机制的贡献众所周知,但这些活性背后的详细分子和细胞机制仍有待阐明。此外,尽管已经鉴定出 PDI 和 ERO1 抑制剂,但以前研究的结果需要仔细评估,因为许多这些药物不是选择性的,并且可能具有显著的细胞毒性。已经广泛研究了 PDI 和 ERO1 在 ER 中的功能。需要进一步的研究来定义它们在 ER 之外的功能。